Table 2.
Clinical and laboratory markers of adult PLHIV receiving ART in Somali region, Ethiopia (N = 784), May 2013
| Variables | Total (N,%) | Dead (N,%) | Active (N,%) | Log-rank P |
|---|---|---|---|---|
| Functional status | ||||
| Working | 434 (55.4%) | 12 (13.8%) | 422 (60.5%) | 0.000 |
| Ambulatory | 242 (30.9%) | 37 (42.5%) | 205 (29.4%) | |
| Bedridden | 108 (13.8%) | 38 (43.7%) | 70 (10.0%) | |
| WHO staging | ||||
| Stage I & II | 329 (42.0%) | 10 (11.5%) | 319 (45.8%) | 0.000 |
| Stage III | 327 (41.7%) | 38 (43.7%) | 289 (41.5%) | |
| Stage IV | 128 (16.3%) | 39 (44.8%) | 89 (12.8%) | |
| BMI for age | ||||
| ≥18.5 Kg/m2 | 335 (42.7%) | 23 (26.4%) | 312 (44.8%) | 0.000 |
| < 18.5 Kg/m2 | 449 (57.3%) | 64 (73.6%) | 385 (55.2%) | |
| Cotrimoxazole | ||||
| Given | 658 (83.9%) | 66 (75.9%) | 592 (84.9%) | 0.032 |
| Not given | 126 (16.1%) | 21 (24.1%) | 105 (15.1%) | |
| INH Given | ||||
| Given | 61 (7.8%) | 20 (23.0%) | 41 (5.9%) | 0.000 |
| Not given | 723 (92.2%) | 67 (77.0%) | 656 (98.3%) | |
| TB co-infected | ||||
| Yes | 311 (39.7%) | 45 (51.7%) | 266 (38.2%) | 0.015 |
| No | 473 (60.3%) | 42 (48.3%) | 431 (61.8%) | |
| Weight (Kg) + | 50 (44-56) |
43 (37-50) |
51 (45-56) |
0.000 |
| CD4 (cells/ µL) + | 146 (102-196) |
48 (31-99) |
156 (116-206) |
0.000 |
| Hemoglobin (g/dL) + | 11.5 (10.0-13.0) |
9.4 (7.9-11.3) |
11.8 (10.3-13.1) |
0.000 |
+
Median value (25th-75th percentile)